发明授权
US5661023A Production and purification of retroviral particles using tentacle anion
exchange
失效
使用触角阴离子交换生产和纯化逆转录病毒颗粒
- 专利标题: Production and purification of retroviral particles using tentacle anion exchange
- 专利标题(中): 使用触角阴离子交换生产和纯化逆转录病毒颗粒
-
申请号: US613920申请日: 1996-03-11
-
公开(公告)号: US5661023A公开(公告)日: 1997-08-26
- 发明人: Michael E. Hrinda , Christopher P. Prior , Jonathan J. Mitschelen , Thomas W. Irish , David M. Weber , Richard S. Gore , James J. Harter , Pierre M. Bay , George C. Tarr
- 申请人: Michael E. Hrinda , Christopher P. Prior , Jonathan J. Mitschelen , Thomas W. Irish , David M. Weber , Richard S. Gore , James J. Harter , Pierre M. Bay , George C. Tarr
- 申请人地址: CA Carlsbad
- 专利权人: The Immune Response Corporation
- 当前专利权人: The Immune Response Corporation
- 当前专利权人地址: CA Carlsbad
- 主分类号: C07K14/15
- IPC分类号: C07K14/15 ; C07K14/16 ; C12M3/00 ; C12N5/02 ; C12N7/02
摘要:
This invention is directed to a continuous process for producing viral particles by providing in a perfused growth medium a population of viable virally infected non-lytic cells, and removing medium containing said cells at a rate to maintain the steady-state log-phase growth of cells remaining in the perfused growth medium. The invention is also directed to a process for purifying retroviral particles by passing a solution comprising the retroviral particles and contaminants through an anion exchange resin, and eluting the retroviral particles from the resin. The preferred exchange resin is a tentacle anion exchange resin.
公开/授权文献
信息查询